Cargando…

The role of GSK-3 in mood disorders: Preliminary data from an experimental study

INTRODUCTION: The identification of potential biomarkers is crucial to improve the management and treatment of mood disorders. Glycogen synthase kinase-3 (GSK-3) is a multifunctional enzyme with an important role in the etiology of mood disorders. Recent findings suggested GSK-3 as a putative biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvo, G. Di, Rosso, G., Hoxha, E., Teobaldi, E., Balbo, I., Tempia, F., Maina, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475711/ http://dx.doi.org/10.1192/j.eurpsy.2021.1025

Ejemplares similares

Differential diagnosis of unipolar versus bipolar depression by GSK3 levels in peripheral blood: a pilot experimental study
por: Rosso, Gianluca, et al.
Publicado: (2023)

Bipolar disorder and peripartum mood episodes: Epidemiology and clinical correlates
por: Aragno, E., et al.
Publicado: (2021)

Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
por: Di Salvo, Gabriele, et al.
Publicado: (2020)

The role of mood disorders in the longitudinal course of obsessive-compulsive disorder: Preliminary data from a 20-year prospective follow-up study
por: Bramante, S., et al.
Publicado: (2021)

A Psychoanalytic-Derived Brief Psychotherapeutic Approach in the Treatment of Major Depression: Monotherapy Studies
por: Di Salvo, Gabriele, et al.
Publicado: (2022)

Did COVID-19 early lockdown actually lead to a higher rate of relapses in psychiatric patients?
por: Rosso, Gianluca, et al.
Publicado: (2020)

Therapeutic monitoring of mood stabilizers in bipolar disorder
por: Falfel, D., et al.
Publicado: (2021)

Family history of mood disorders and concomitant psychopathology in patients with depression
por: Kasyanov, E., et al.
Publicado: (2021)

Purkinje Cell Signaling Deficits in Animal Models of Ataxia
por: Hoxha, Eriola, et al.
Publicado: (2018)

Mood disorders as a risk factor for family aggregation of somatic diseases
por: Kasyanov, E., et al.
Publicado: (2022)

Elovl5 Expression in the Central Nervous System of the Adult Mouse
por: Balbo, Ilaria, et al.
Publicado: (2021)

Effects of the administration of Elovl5-dependent fatty acids on a spino-cerebellar ataxia 38 mouse model
por: Balbo, Ilaria, et al.
Publicado: (2022)

The role of Effortful Control and Executive Attention in Mood Disorders
por: Ossola, P.
Publicado: (2022)

The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer’s Disease
por: Hoxha, Eriola, et al.
Publicado: (2018)

Boredom, emotional dysregulation and avoidance coping strategies: Which is their role in youth mood disorders?
por: Cicolini, A., et al.
Publicado: (2023)

Clinical dynamics of anhedonia symptom in mood disorder and in alcohol use disorder
por: Roshchina, O., et al.
Publicado: (2021)

Circadian rhythm disturbances in mood disorders: characterisation and clinical impact
por: Cappannini, G., et al.
Publicado: (2023)

Quality of life and mood disorders
por: Smaoui, N., et al.
Publicado: (2021)

Disruptive mood dysregulation disorder
por: Higueras, P. Hervias
Publicado: (2021)

Suicide in Adolescents with Mood Disorders
por: Shah, K., et al.
Publicado: (2022)

Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder
por: Attianese, N., et al.
Publicado: (2023)

Neuron-specific enolase during the therapy in patients with alcohol use disorder and mood disorders
por: Levchuk, L., et al.
Publicado: (2021)

Virtual Reality Cognitive Remediation for Mood disorders: RCT pilot study
por: Lipskaya-Velikovsky, L., et al.
Publicado: (2022)

Movement, mood and cognition: Preliminary insight into the effects of electroconvulsive therapy in depression through a data-driven resting-state connectivity analysis
por: Belge, J.-B., et al.
Publicado: (2021)

Mood disorders and suicides during coronavirus pandemic
por: Shah, K., et al.
Publicado: (2021)

Behavioural Variant of Frontotemporal Dementia or Mood Disorder?
por: Mesquita, B., et al.
Publicado: (2022)

Epigenetic mechanisms and stress coping in mood disorders
por: Hogea, L., et al.
Publicado: (2022)

TRANSPORTATION AND MOOD: THE ROLE OF TRIP CHARACTERISTICS
por: Dabelko-Schoeny, Holly, et al.
Publicado: (2022)

Avatar Intervention for cannabis use disorder in patients with psychotic and mood disorders
por: Giguère, S., et al.
Publicado: (2023)

Altered Functional Connectivity of Salience Network in Mood Disorders
por: Todeva-Radneva, A., et al.
Publicado: (2023)

Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
por: Khattech, D., et al.
Publicado: (2023)

Family history of mood disorder weakens the association between personality traits and suicidality in depressed patients
por: Kibitov, A., et al.
Publicado: (2022)

Guillain-Barre syndrome and mood disorders
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Social Encounters and Mood: The Moderating Role of Narcissism
por: Zhang, Shiyang, et al.
Publicado: (2021)

Anticonvulsant treatment and mood disorders. A Vitamine B12 key role?
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

ADHD Dimension, Childhood trauma and Perceived Stress: an observational study on peripartum women affected by mood and anxiety disorders
por: Bilotta, I., et al.
Publicado: (2023)

Could the mood disorder symptoms can be predict by metabolic disturbances?
por: Rog, J., et al.
Publicado: (2022)

Age at Menarche in Women With Bipolar Disorder: Correlation With Clinical Features and Peripartum Episodes
por: Rosso, Gianluca, et al.
Publicado: (2020)

THE RELATIONSHIP BETWEEN RESIDUAL MOOD SYMPTOMS, DISPOSITIONAL MINDFULNESS, AND QUALITY OF LIFE IN BIPOLAR DISORDER
por: Piazza, F. P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sqar46e78hnsjcunva4km5kme1